About Oculis Holding AG 
Oculis Holding AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 3 Schemes (2.67%)
Foreign Institutions
Held by 8 Foreign Institutions (1.44%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-31 Million
Pharmaceuticals & Biotechnology
USD 1,043 Million ()
NA (Loss Making)
NA
0.00%
-1.12
-52.47%
5.80






